SCHEMBL24258319

SCHEMBL24258319

CCNCC1CCc2ccccc2C1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.57
ADRA1A P35348 1/20 0.57
ADRA1B P35368 1/20 0.57
NPY1R P25929 4/20 0.50
NPY5R Q15761 4/20 0.50
MTNR1A P48039 3/20 0.49
MTNR1B P49286 3/20 0.49
CYP19A1 P11511 1/20 0.47
HTR1A P08908 3/20 0.47
HTR1D P28221 1/20 0.47
DRD2 P14416 1/20 0.46
ADRA2C P18825 1/20 0.46
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
GBA1 P04062 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
SIGMAR1 Q99720 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12422869 0.89 ADRA1D (0.58) ADRA1DADRA1AADRA1BNPY1RNPY5R
SCHEMBL9567984 0.82 ADRA1D (0.52) ADRA1DADRA1AADRA1BNPY1RNPY5R
SCHEMBL599314 0.80 CYP19A1 (0.54) ADRA1DADRA1AADRA1BMTNR1AMTNR1B
SCHEMBL9082016 0.78 ADRA1D (0.74) ADRA1DADRA1AADRA1BHTR1AHTR1D
SCHEMBL9139949 0.77 HTR1A (0.53) ADRA1DADRA1AADRA1BMTNR1AMTNR1B
SCHEMBL15701675 0.76 CYP19A1 (0.54) ADRA1DADRA1AADRA1BMTNR1AMTNR1B
SCHEMBL1689627 0.76 CYP19A1 (0.54) ADRA1DADRA1AADRA1BMTNR1AMTNR1B
SCHEMBL6570371 0.76 CYP19A1 (0.54) ADRA1DADRA1AADRA1BMTNR1AMTNR1B
SCHEMBL8713442 0.76 MTNR1A (0.52) ADRA1DADRA1AADRA1BNPY1RNPY5R
SCHEMBL9629132 0.76 NPY5R (0.60) ADRA1DADRA1AADRA1BNPY1RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed